# Active Implants

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/active-implants

- Industry: Medical Devices & Equipment
- Headquarters: Memphis, US
- Website: www.activeimplants.com
- Total disclosed funding: $10M
- Latest round: Series D (Mar 16, 2017)
- Investors on record: 1

## About

Active Implants LLC is a company focused on developing and commercializing orthopedic implants to improve outcomes in joint surgeries, addressing unmet clinical needs in joint replacement and repair.Founded in 2004 and headquartered in Memphis, US, Active Implants LLC specializes in innovative orthopedic solutions. The company has engaged in 15 deals, with the most recent funding round being a VENTURE DEBT round on January 29, 2019, where they raised USD 36.78 mn, bringing the total amount raised to USD 10.00 mn. The founder, Sandra Steinberg, has a background in the healthcare industry, although no information about previous ventures is provided. Ted Davis currently serves as the CEO.Active Implants specializes in the development and commercialization of innovative orthopedic implants designed to enhance patient outcomes in joint surgeries. Their core product offerings include advanced implant solutions targeting conditions such as arthritis and joint degeneration, aimed at providing effective solutions for pain management and improved mobility. The company caters to a diverse client base, including orthopedic surgeons and hospitals across North America and select regions in Europe and Asia.Active Implants generates revenue through direct sales of its orthopedic implant products to hospitals and surgical centers under a B2B model. Pricing strategies reflect the innovative design and clinical benefits of the implants, often structured around bulk purchasing or long-term supply contracts, fostering strong partnerships with healthcare providers for ongoing business.Active Implants is focused on expanding its product line and geographic reach. The company is designing new implant solutions to be launched in the coming years, targeting additional markets in Europe and Asia. The recent VENTURE DEBT funding of USD 36.78 mn will be utilized to support these initiatives, allowing for enhanced research and development, and facilitating entry into new markets to broaden their client base.

## Funding rounds

- Series D, Mar 16, 2017, $10M — LS Health Science Partners

## Investors

- LS Health Science Partners (https://capitalatlas.ai/funds/ls-health-science-partners) — Series D